Clinical Trial Market Research Reports & Industry Analysis

Key Highlights The argininosuccinic aciduria market is anticipated to sustain a steady Compound Annual Growth Rate (CAGR) during the forecast period (2025–2034). This growth in market revenue is primarily propelled by advancements in diagnostic techniques, heightened awareness of the condition, and ...

Key Highlights Although considered rare, the true prevalence of EDS is anticipated to be higher than currently appreciated, primarily due to a lack of awareness among the healthcare community. Hypermobile Ehlers-Danlos Syndrome (hEDS) is the most common subtype of EDS, accounting for approximately 9 ...

Key Highlights Alkaptonuria or ""black urine disease,"" is a rare genetic disorder now manageable with Food and Drug administration (FDA)-approved HARLIKU (nitisinone), which, alongside dietary restrictions of tyrosine and phenylalanine, helps reduce toxic HGA buildup and slow disease progression. A ...

Key Highlights With declining rates of head and neck cancers related to alcohol and tobacco, HPV has become the principal etiologic factor in OPSCC, redefining prognostic outlooks and informing the development of tailored therapeutic approaches. Patients with HPV-positive oropharyngeal tumors exhibi ...

The global locally advanced pancreatic cancer market size reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.38 billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033. Locally advanced pancreatic cancer refers to a stage of pancreatic cancer where the tumor is c ...

Report Scope The report examines trends in the global market for AI in clinical trials. It segments the global market by component, phase, deployment mode, therapeutic area and end user. It also provides insights into key emerging trends and potential growth drivers. Components consist of software a ...

China's Evolution in Global Drug Development and Clinical Trials Summary In 2015, China’s state council launched ‘Opinions on Deepening the Reform of the Review and Approval Processes to Encourage Innovation of Drugs and Medical Devices,’ which was the catalyst of change to implement several regulat ...

The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies ...

Global Artificial Intelligence in Clinical Trials Market to Reach US$3.5 Billion by 2030 The global market for Artificial Intelligence in Clinical Trials estimated at US$1.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 202 ...

Global e-Clinical Trial Technologies Market to Reach US$31.1 Billion by 2030 The global market for e-Clinical Trial Technologies estimated at US$14.8 Billion in the year 2024, is expected to reach US$31.1 Billion by 2030, growing at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial ...

Global Electronic Data Capture Market to Reach US$2.7 Billion by 2030 The global market for Electronic Data Capture estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 13.6% over the analysis period 2024-2030. Services Component, one of the ...

Global Healthcare Contract Research Organization (CRO) Market to Reach US$83.6 Billion by 2030 The global market for Healthcare Contract Research Organization (CRO) estimated at US$61.1 Billion in the year 2024, is expected to reach US$83.6 Billion by 2030, growing at a CAGR of 5.4% over the analysi ...

Global Regulatory Affairs Outsourcing Market to Reach US$9.2 Billion by 2030 The global market for Regulatory Affairs Outsourcing estimated at US$5.6 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Regulatory Submis ...

Global Alzheimer’s Disease Drugs Market to Reach US$12.3 Billion by 2030 The global market for Alzheimer’s Disease Drugs estimated at US$8.9 Billion in the year 2024, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Donepezil, one of the seg ...

Global eClinical Solutions Market to Reach US$22.7 Billion by 2030 The global market for eClinical Solutions estimated at US$11.4 Billion in the year 2024, is expected to reach US$22.7 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Web-Hosted (on-demand) Delivery, on ...

Global Artificial Intelligence-based Clinical Trial Solutions for Patient Matching Market to Reach US$2.4 Billion by 2030 The global market for Artificial Intelligence-based Clinical Trial Solutions for Patient Matching estimated at US$641.6 Million in the year 2024, is expected to reach US$2.4 Bill ...

Global Veterinary Clinical Trials Market to Reach US$7.6 Billion by 2030 The global market for Veterinary Clinical Trials estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Companion Animal, one of ...

Global Ophthalmic Clinical Trials Market to Reach US$2.7 Billion by 2030 The global market for Ophthalmic Clinical Trials estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Drugs, one of the segment ...

Global Clinical Trial Management Systems (CTMS) Market to Reach US$4.5 Billion by 2030 The global market for Clinical Trial Management Systems (CTMS) estimated at US$2.0 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2024-20 ...

Global Metaverse in Healthcare Market to Reach US$159.1 Billion by 2030 The global market for Metaverse in Healthcare estimated at US$15.4 Billion in the year 2024, is expected to reach US$159.1 Billion by 2030, growing at a CAGR of 47.6% over the analysis period 2024-2030. Metaverse Software, one o ...

Global Clinical Trial Imaging Market to Reach US$1.4 Billion by 2030 The global market for Clinical Trial Imaging estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Project & Data Management Service ...

Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach US$1.7 Billion by 2030 The global market for Acute Myeloid Leukemia (AML) Therapeutics estimated at US$785.7 Million in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 202 ...

Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach US$7.8 Billion by 2030 The global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis per ...

Global Clinical Data Analytics Market to Reach US$193.1 Billion by 2030 The global market for Clinical Data Analytics estimated at US$39.1 Billion in the year 2024, is expected to reach US$193.1 Billion by 2030, growing at a CAGR of 30.5% over the analysis period 2024-2030. Quality Care Application, ...

Global Biosimulation Technology Market to Reach US$8.5 Billion by 2030 The global market for Biosimulation Technology estimated at US$3.6 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 15.6% over the analysis period 2024-2030. Biosimulation Software, one ...